The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the data suggest that that therapy does reduce um the incidence of a recurrence though it's not clear that it translates to a survival benefit so there's a little bit of controversy there although within that Community it doesn't seem very controversial most oncologists I speak with are are pretty adamant that that therapy be used and and again they can point to you know the clinical trials that demonstrate a reduction in recurrence of cancer
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.